Other
disease
disease is an intervention with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Trials by Status
completed250%
unknown125%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
completed
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
NCT06002750
completed
Peri-implant Conditions Mimic Periodontal Conditions
NCT06128850
not_yet_recruiting
Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical Complex
NCT06371001
unknown
Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute
NCT05465759
Clinical Trials (4)
Showing 4 of 4 trials
NCT06002750
Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
NCT06128850
Peri-implant Conditions Mimic Periodontal Conditions
NCT06371001
Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical Complex
NCT05465759
Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4